Request

What is the total amount that has been spent on legal fees and medical expert witness costs for tribunals related to VDPS claims linked specifically to the Covid-19 vaccines since NHSBS took over running the scheme?

Date Range: 01/11/21 – 20/11/24

Response

can confirm that the NHSBSA holds the information you have requested.

As background, an applicant under the scheme can challenge the decision made about their Vaccine Damage Payment claim. This is called asking for a “Mandatory Reversal” and means the claim will be reassessed.

If the applicant disagrees with the independent medical assessor’s decision in relation to a mandatory reversal, they can either: • submit a reversal – this means the claim will be reassessed. There is no limit on the number of times an applicant can make this request. • submit an appeal to the Social Security and Child Support Tribunal.

The NHSBSA takes an objective approach at all stages of the appeals process and welcomes any teaching that the courts provide. More information on this process is available on the gov.uk website.

The total spend from 1 November 2021 to 20 November 2024 in relation to Vaccine Damage Payment appeals heard by a tribunal is: • £50,608.00 for legal fees • £0 for medical expert witness costs

Tribunals are managed by His Majesty’s Courts and Tribunals Service (HMCTS) and the figures above only include legal fees paid to our third party supplier and do not include costs paid to HMTCS.

Publishing this response

Please note that this information will be published on our Freedom of Information disclosure log at:

https://opendata.nhsbsa.net/dataset/foi-02407

Your personal details will be removed from the published response.

Data Queries

Please contact foirequests@nhsbsa.nhs.uk ensuring you quote the above reference if you have any specific questions regarding this response; or, if you feel you may be misunderstanding or misinterpreting the information; or, if you plan on publishing the data.

Reusing the data and copyright

If you plan on producing a press or broadcast story based upon the data please contact communicationsteam@nhsbsa.nhs.uk. This is important to ensure that the figures are not misunderstood or misrepresented.

The information supplied to you continues to be protected by the Copyright, Designs and Patents Act 1988 and is subject to NHSBSA copyright. This information is licenced under the terms of the Open Government Licence detailed at:

http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/

Should you wish to re-use the information you must include the following statement: “NHSBSA Copyright 2024” Failure to do so is a breach of the terms of the licence.

Information you receive which is not subject to NHSBSA Copyright continues to be protected by the copyright of the person, or organisation, from which the information originated. Please obtain their permission before reproducing any third party (non NHSBSA Copyright) information.